374 related articles for article (PubMed ID: 28069701)
1. Loss of Axin2 results in impaired heart valve maturation and subsequent myxomatous valve disease.
Hulin A; Moore V; James JM; Yutzey KE
Cardiovasc Res; 2017 Jan; 113(1):40-51. PubMed ID: 28069701
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of Circulating Monocytes Ameliorates the Progression of Myxomatous Valve Degeneration in Marfan Syndrome.
Kim AJ; Xu N; Umeyama K; Hulin A; Ponny SR; Vagnozzi RJ; Green EA; Hanson P; McManus BM; Nagashima H; Yutzey KE
Circulation; 2020 Jan; 141(2):132-146. PubMed ID: 31928435
[TBL] [Abstract][Full Text] [Related]
3. Loss of β-catenin promotes chondrogenic differentiation of aortic valve interstitial cells.
Fang M; Alfieri CM; Hulin A; Conway SJ; Yutzey KE
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2601-8. PubMed ID: 25341799
[TBL] [Abstract][Full Text] [Related]
4. Dynamic changes in mitral valve extracellular matrix, tissue mechanics and function in a mouse model of Marfan syndrome.
Gonzalez BA; Harmeyer SW; Song T; Sadayappan S; Yutzey KE
Matrix Biol; 2024 Feb; 126():1-13. PubMed ID: 38185344
[TBL] [Abstract][Full Text] [Related]
5. Nonbiased Molecular Screening Identifies Novel Molecular Regulators of Fibrogenic and Proliferative Signaling in Myxomatous Mitral Valve Disease.
Thalji NM; Hagler MA; Zhang H; Casaclang-Verzosa G; Nair AA; Suri RM; Miller JD
Circ Cardiovasc Genet; 2015 Jun; 8(3):516-28. PubMed ID: 25814644
[TBL] [Abstract][Full Text] [Related]
6. Macrophage Transitions in Heart Valve Development and Myxomatous Valve Disease.
Hulin A; Anstine LJ; Kim AJ; Potter SJ; DeFalco T; Lincoln J; Yutzey KE
Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):636-644. PubMed ID: 29348122
[TBL] [Abstract][Full Text] [Related]
7. Wnt/β-catenin signaling enables developmental transitions during valvulogenesis.
Bosada FM; Devasthali V; Jones KA; Stankunas K
Development; 2016 Mar; 143(6):1041-54. PubMed ID: 26893350
[TBL] [Abstract][Full Text] [Related]
8. Deletion of Fstl1 (Follistatin-Like 1) From the Endocardial/Endothelial Lineage Causes Mitral Valve Disease.
Prakash S; Borreguero LJJ; Sylva M; Flores Ruiz L; Rezai F; Gunst QD; de la Pompa JL; Ruijter JM; van den Hoff MJB
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):e116-e130. PubMed ID: 28705792
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome.
Ng CM; Cheng A; Myers LA; Martinez-Murillo F; Jie C; Bedja D; Gabrielson KL; Hausladen JM; Mecham RP; Judge DP; Dietz HC
J Clin Invest; 2004 Dec; 114(11):1586-92. PubMed ID: 15546004
[TBL] [Abstract][Full Text] [Related]
10. Krox20 heterozygous mice: A model of aortic regurgitation associated with decreased expression of fibrillar collagen genes.
Théron A; Odelin G; Faure E; Avierinos JF; Zaffran S
Arch Cardiovasc Dis; 2016 Mar; 109(3):188-98. PubMed ID: 26711547
[TBL] [Abstract][Full Text] [Related]
11. Coordinated action of Axin1 and Axin2 suppresses β-catenin to regulate muscle stem cell function.
Figeac N; Zammit PS
Cell Signal; 2015 Aug; 27(8):1652-65. PubMed ID: 25866367
[TBL] [Abstract][Full Text] [Related]
12. Wnt Signaling Inhibition Prevents Postnatal Inflammation and Disease Progression in Mouse Congenital Myxomatous Valve Disease.
Xu N; Alfieri CM; Yu Y; Guo M; Yutzey KE
Arterioscler Thromb Vasc Biol; 2024 Apr; ():. PubMed ID: 38660802
[TBL] [Abstract][Full Text] [Related]
13. Loss of Krox20 results in aortic valve regurgitation and impaired transcriptional activation of fibrillar collagen genes.
Odelin G; Faure E; Kober F; Maurel-Zaffran C; Théron A; Coulpier F; Guillet B; Bernard M; Avierinos JF; Charnay P; Topilko P; Zaffran S
Cardiovasc Res; 2014 Dec; 104(3):443-55. PubMed ID: 25344368
[TBL] [Abstract][Full Text] [Related]
14. Novel mutations of AXIN2 identified in a Chinese Congenital Heart Disease Cohort.
Zhu MJ; Ma XY; Ding PC; Tang HF; Peng R; Lu L; Li PQ; Qiao B; Yang XY; Zheng YF; Wang HY; Gao YQ; Chen FS
J Hum Genet; 2019 May; 64(5):427-435. PubMed ID: 30760879
[TBL] [Abstract][Full Text] [Related]
15. Bone Morphogenetic Protein Signaling Is Required for Aortic Valve Calcification.
Gomez-Stallons MV; Wirrig-Schwendeman EE; Hassel KR; Conway SJ; Yutzey KE
Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1398-405. PubMed ID: 27199449
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia promotes primitive glycosaminoglycan-rich extracellular matrix composition in developing heart valves.
Amofa D; Hulin A; Nakada Y; Sadek HA; Yutzey KE
Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1143-H1154. PubMed ID: 28842437
[TBL] [Abstract][Full Text] [Related]
17. TGF-β signalling and reactive oxygen species drive fibrosis and matrix remodelling in myxomatous mitral valves.
Hagler MA; Hadley TM; Zhang H; Mehra K; Roos CM; Schaff HV; Suri RM; Miller JD
Cardiovasc Res; 2013 Jul; 99(1):175-84. PubMed ID: 23554457
[TBL] [Abstract][Full Text] [Related]
18. Emerging pathogenic mechanisms in human myxomatous mitral valve: lessons from past and novel data.
Hulin A; Deroanne C; Lambert C; Defraigne JO; Nusgens B; Radermecker M; Colige A
Cardiovasc Pathol; 2013; 22(4):245-50. PubMed ID: 23261354
[TBL] [Abstract][Full Text] [Related]
19. Cadherin-11 Overexpression Induces Extracellular Matrix Remodeling and Calcification in Mature Aortic Valves.
Sung DC; Bowen CJ; Vaidya KA; Zhou J; Chapurin N; Recknagel A; Zhou B; Chen J; Kotlikoff M; Butcher JT
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1627-37. PubMed ID: 27312222
[TBL] [Abstract][Full Text] [Related]
20. Stress-induced remodelling of the mitral valve: a model for leaflet thickening and superimposed tissue formation in mitral valve disease.
Kruithof BPT; Paardekooper L; Hiemstra YL; Goumans MJ; Palmen M; Delgado V; Klautz RJM; Ajmone Marsan N
Cardiovasc Res; 2020 Apr; 116(5):931-943. PubMed ID: 31497851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
